GoodRx (GDRX) Reports Q2 Earnings: What Key Metrics Have to Say

GoodRx Holdings, Inc. (GDRX) reported $200.61 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 5.8%. EPS of $0.08 for the same period compares to $0.07 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $200.68 million, representing a surprise of -0.03%. The company delivered an EPS surprise of -11.11%, with the consensus EPS estimate being $0.09. While investors closely watch year-over-year changes in headline numbers -- revenue and ear ...